Phase 2
N=7
Thymus Transplantation Dose in DiGeorge #932
DiGeorge Anomaly · DiGeorge Syndrome · Complete DiGeorge Anomaly · Complete DiGeorge Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT00576836 ↗Enrolled (actual)
7
Serious AEs
85.7%
Results posted
Feb 2020
Primary outcome: Primary: Survival at 1 Year Post-CTTI — 83 % of participants who survive to 1 year
Study Design & Population
- Study type
- Interventional
- Phase
- Phase 2
- Interventions
- Cultured Thymus Tissue Implantation (CTTI) (Biological); Cultured Thymus Tissue Implantation with Parathyroid Transplantation (Other)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Sumitomo Pharma Switzerland GmbH
- Primary completion
- Nov 2010
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Survival at 1 Year Post-CTTI |
83 | — |
| SECONDARY Survival at 2 Years Post-CTTI |
83 | — |
| SECONDARY Immune Reconstitution Efficacy - CD3 T Cells |
635 | — |
| SECONDARY Immune Reconstitution Efficacy - CD4 T Cells |
499 | — |
| SECONDARY Immune Reconstitution Efficacy - CD8 T Cells |
116 | — |
| SECONDARY Immune Reconstitution Efficacy - Naive CD4 T Cells |
279 | — |
| SECONDARY Immune Reconstitution Efficacy - Naive CD8 T Cells |
214 | — |
| SECONDARY Immune Reconstitution Efficacy - Response to Mitogens |
135016 | — |
| SECONDARY Thymus Allograft Biopsy |
1; 0; 1 | — |
Summary
One purpose of this study is to determine whether the amount of cultured thymus tissue implanted into DiGeorge anomaly infants has any effect on the immune outcome. Another purpose of this study is to determine whether parental parathyroid transplantation (in addition to cultured thymus tissue implantation (CTTI) can help both the immune and the calcium problems in DiGeorge infants with hypocalcemia. [Funding Source - FDA Office of Orphan Products Development (OOPD)]
Eligibility Criteria
Thymus Transplant Inclusion Criteria:
- A parent or guardian of the DGS subject signed the consent form.
- Medical screening was completed.
- For a diagnosis of DGS, the subject had to have one of the following:
- Congenital heart disease;
- Hypocalcemia requiring replacement;
- 22q11.2 hemizygosity or 10p13 hemizygosity;
- CHARGE association or CHD7 mutation;
- A subject with abnormal ears whose mother had diabetes (type I, type II, or gestational).
- To meet the criteria of typical complete DiGeorge Anomaly (cDGA), the subject had to have either:
- Circulating CD3+ T cell count by flow cytometry 18 years old
- Answers all questionnaire items and meets safety screening criteria
- Normal serum calcium
- Normal PTH function
- HLA typing consistent with parentage
- Parent chosen for donation will share HLA-DR allele in thymus donor; if not applicable, then either parent will be selected (if meet all other criteria).
- Must not be on anticoagulation or can come off for donation/transplantation
Parental Parathyroid Donor Exclusion:
- Donor is only living involved parent or caretaker of the recipient
- Hypoparathyroidism - low parathyroid hormone (PTH) in presence of low serum calcium and high serum phosphate
- Hyperparathyroidism (or history of) - elevated PTH in presence of high serum calcium and low serum phosphate
- History of cancer
- Evidence of any of following: HIV-1, HIV-2, HTLV-1, HTLV-2, syphilis, hepatitis B, hepatitis C, West Nile virus, or Trypanosoma Cruzi (Chagas disease)
- Elevated AST, ALT, alkaline phosphatase > 3 times upper limit of normal
- History including receipt of a xenograft or risk factors for SARS, Mad Cow - Disease or smallpox. Note: if parent has Mad Cow Disease risk factors (but not active disease), parent(s) may give permission for transplantation.
- CMV positive urine
- Positive CMV IgM antibodies
- Positive IgM anti-EBV VCA
- On blood thinners and cannot stop for the parathyroid donation
- Elevated PT or PTT (> ULN)
- Platelets < 100,000
- Positive Toxoplasma IgM
- The donor will receive a history and physical; may be excluded based on PI's medical judgment
- Hemoglobin < 9 g/dl
- Infectious lesion on head or neck
- Goiter on ultrasound
- Abnormal fiberoptic laryngoscopy of vocal cords
- Pregnancy
- Positive HSV IgG is not an exclusion; however, post transplantation prophylaxis is needed
- Positive VZV IgG is not an exclusion; however, post transplantation prophylaxis is needed
- Medical concern of otolaryngologist
- Concern by medical psychologist or social worker. Parents are interviewed together and separately regarding following areas: medical history; health habits; substance use; relationships and support; education/work history; mental status/psychological history; readiness for donation.
- Questionnaire (safety screening) responses can lead to exclusion.
Biological Mother of DiGeorge Subject Inclusion Criteria:
- Competent to provide consent
- Willing to provide blood for testing (No other inclusion/exclusion for mother)
Data sourced from ClinicalTrials.gov (NCT00576836). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.